26
https://pubmed.ncbi.nlm.nih.gov/38113126
A patient with refractory multiple myeloma and indolent systemic mastocytosis successfully underwent isatuximab desensitization, as presented in this case report.
“Patient with Refractory Multiple Myeloma and Indolent Systemic Mastocytosis Successfully Undergoes Isatuximab Desensitization: A Case Report”
